Nov 28, 2023 / 11:00PM GMT
Geoff Cumming Munich Limited-Moderator
My name is Geoff Cumming, normally Chairman of Munich Limited. So this year has seen many of the objectives that we laid out this time last year and presented to you that achieved has been pleasing progress in laying the foundations for commercial success in each of our two focus areas. We're satisfied that the organizational structure we have in place provides us with the platform from which commercial success can be attained.
We remain focused on advancing the development and commercialization of Sat-Fi two in cancer detection and S&S extra Exosome isolation platforms. We've sought to validate our core technologies and establish a broad product span to diagnostic pipeline with multiple partnering opportunities.
These initiatives Jack, again, clinical validation all suffered when [CA 15 3] test for breast cancer detection and a commercial partnership pool for Omega cooperation in our ExteNet zone capture technology. These milestones significantly derisked at its core technologies drove early Internet revenues about our sub BGM
INOVIQ Ltd Annual Shareholders Meeting Transcript
Mar 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers